Patent number: 10874636
Abstract: Disclosed is an application of substituted cinnamamide derivatives in the preparation of anti-anxiety medications, the substituted cinnammide derivatives are compounds having the structure of formula (I) or pharmaceutically acceptable salts thereof, wherein, R1 is —H, —OH, —F, —Cl, —Br, —I, —OCH3, —OCF3, —OCHF2, —OCH2F, —CF3, —CHF2, —CH2F, —CH3, —CH3CH2, —CF3CH2, —CN, —NO2, —NH2 or —COOR5; R2 is H, C1-C10 linear alkyl, C3-C10 branched alkyl, C3-C10 cyclic alkyl, C1-C10 hydroxyalkyl or a N-substituted piperazine-derived group; or R2 is a group forming with adjacent Y a tetrahydropyrrolyl group, a piperidyl group or a cyclohexanimido group.
Type:
Grant
Filed:
January 20, 2017
Date of Patent:
December 29, 2020
Assignee:
Tasly Pharmaceutical Group Co., Ltd.
Inventors:
Min Han, Xiaohui Ma, Wangyi Zhou, Yanyong Liu, Yanchuan Li, Jing Wang, Shuiping Zhou, He Sun, Yonghong Zhu
Publication number: 20190046500
Abstract: Disclosed is an application of substituted cinnamamide derivatives in the preparation of anti-anxiety medications, the substituted cinnammide derivatives are compounds having the structure of formula (I) or pharmaceutically acceptable salts thereof, wherein, R1 is —H, —OH, —F, —Cl, —Br, —I, —OCH3, —OCF3, —OCHF2, —OCH2F, —CF3, —CHF2, —CH2F, —CH3, —CH3CH2, —CF3CH2, —CN, —NO2, —NH2 or —COOR5; R2 is H, C1-C10 linear alkyl, C3-C10 branched alkyl, C3-C10 cyclic alkyl, C1-C10 hydroxyalkyl or a N-substituted piperazine-derived group; or R2 is a group forming with adjacent Y a tetrahydropyrrolyl group, a piperidyl group or a cyclohexanimido group.
Type:
Application
Filed:
January 20, 2017
Publication date:
February 14, 2019
Inventors:
Min HAN, Xiaohui MA, Wangyi ZHOU, Yanyong LIU, Yanchuan LI, Jing WANG, Shuiping ZHOU, He SUN, Yonghong ZHU
